Effects of NAD+ in Caenorhabditis elegans Models of Neuronal Damage
Open accessAbstract
Nicotinamide adenine dinucleotide (NAD+) is an essential cofactor that mediates numerous biological processes in all living cells. Multiple NAD+ biosynthetic enzymes and NAD+-consuming enzymes are involved in neuroprotection and axon regeneration. The nematode Caenorhabditis elegans has served as a model to study the neuronal role of NAD+ because many molecular components regulating NAD+ are highly conserved. This review focuses on recent findings using C. elegans models of neuronal damage pertaining to the neuronal functions of NAD+ and its precursors, including a neuroprotective role against excitotoxicity and axon degeneration as well as an inhibitory role in axon regeneration. The regulation of NAD+ levels could be a promising therapeutic strategy to counter many neurodegenerative diseases, as well as neurotoxin-induced and traumatic neuronal damage.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Trigonelline is metabolized via the NAPRT/Preiss-Handler pathway across models.
“Mechanistically, trigonelline does not activate GPR109A but is metabolized via the nicotinate phosphoribosyltransferase/Preiss–Handler pathway5,6 across models.”
From Trigonelline Is an NAD+ Precursor That Improves Muscle Function during Ageing and Is Reduced in Human Sarcopenia (2024) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 3,151 · see citing works
Ankarcrona, M., Dypbukt, J. M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S. A., & Nicotera, P. (1995) · Neuron · doi:10.1016/0896-6273(95)90186-8 · Cited by 1,884 · see citing works
Fang, E. F., Hou, Y., Palikaras, K., Adriaanse, B. A., Kerr, J. S., Yang, B., Lautrup, S., Hasan-Olive, M. M., Caponio, D., Dan, X., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0332-9 · Cited by 1,740 · see citing works
Sirtuins in mammals: insights into their biological function
Michán, S., & Sinclair, D. A. (2007) · Biochemical Journal · doi:10.1042/bj20070140 · Cited by 1,719 · see citing works
Cantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648 · see citing works
Kynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530 · see citing works
Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
Araki, T., Sasaki, Y., & Milbrandt, J. (2004) · Science · doi:10.1126/science.1098014 · Cited by 1,060 · see citing works
NAD+ metabolism in health and disease
Belenky, P. A., Bogan, K. L., & Brenner, C. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.11.006 · Cited by 983 · see citing works
Waller, A. V. (1850) · Philosophical Transactions of the Royal Society of London · doi:10.1098/rstl.1850.0021 · Cited by 889 · see citing works
Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
Zajączkowska, R., Kocot-Kępska, M., Leppert, W., Wrzosek, A., Mika, J., & Wordliczek, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061451 · Cited by 833 · see citing works
Bieganowski, P., & Brenner, C. (2004) · Cell · doi:10.1016/s0092-8674(04)00416-7 · Cited by 750 · see citing works
Chronic Glutamate Toxicity in Neurodegenerative Diseases—What is the Evidence?
Lewerenz, J., & Maher, P. A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00469 · Cited by 721 · see citing works
dSarm/Sarm1 Is Required for Activation of an Injury-Induced Axon Death Pathway
Osterloh, J. M., Yang, J. H., Rooney, T. M., Fox, A. N., Adalbert, R., Powell, E. H., Sheehan, A. E., Avery, M. A., Hackett, R., Logan, M. A., et al. (2012) · Science · doi:10.1126/science.1223899 · Cited by 688 · see citing works
Axonal Self-Destruction and Neurodegeneration
Raff, M., Whitmore, A., & Finn, J. (2002) · Science · doi:10.1126/science.1068613 · Cited by 670 · see citing works
Intrinsic Control of Axon Regeneration
He, Z., & Jin, Y. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.022 · Cited by 652 · see citing works
Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve
Lunn, E. R., Perry, V. H., Brown, M. C., Rosen, H., & Gordon, S. (1989) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1989.tb00771.x · Cited by 646 · see citing works
Enhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity
Sorrentino, V., Romani, M., Mouchiroud, L., Beck, J. S., Zhang, H., D’Amico, D., Moullan, N., Potenza, F., Schmid, A. W., Rietsch, S., et al. (2017) · Nature · doi:10.1038/nature25143 · Cited by 630 · see citing works
Wallerian degeneration: an emerging axon death pathway linking injury and disease
Conforti, L., Gilley, J., & Coleman, M. P. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3680 · Cited by 611 · see citing works
Functional regeneration after laser axotomy
Yanik, M. F., Cinar, H., Cinar, H. N., Chisholm, A. D., Jin, Y., & Ben-Yakar, A. (2004) · Nature · doi:10.1038/432822a · Cited by 598 · cited 2× · see citing works
“For example, the axonal injury of motor neurons causes locomotory defects, and regenerating this injured axon is likely required to recover the animal’s locomotion [77].”
BackgroundQuinolinic acid, the inescapable neurotoxin
Guillemin, G. J. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08485.x · Cited by 595 · see citing works
SARM1 activation triggers axon degeneration locally via NAD <sup>+</sup> destruction
Gerdts, J., Brace, E. J., Sasaki, Y., DiAntonio, A., & Milbrandt, J. (2015) · Science · doi:10.1126/science.1258366 · Cited by 593 · see citing works
Metals, oxidative stress and neurodegeneration: A focus on iron, manganese and mercury
Farina, M., Ávila, D. S., da Rocha, J. B. T., & Aschner, M. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.006 · Cited by 558 · see citing works
Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons
Parker, J. A., Arango-Lievano, M., Abderrahmane, S., Lambert, E., Tourette, C., Catoire, H., & Néri, C. (2005) · Nature Genetics · doi:10.1038/ng1534 · Cited by 509 · see citing works
SIRT1 in Neurodevelopment and Brain Senescence
Herskovits, A. Z., & Guarente, L. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.028 · Cited by 493 · see citing works
Endogenous Nmnat2 Is an Essential Survival Factor for Maintenance of Healthy Axons
Gilley, J., & Coleman, M. P. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000300 · Cited by 472 · see citing works
Sirtuin activators and inhibitors: Promises, achievements, and challenges
Dai, H., Sinclair, D. A., Ellis, J. L., & Steegborn, C. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.03.004 · Cited by 463 · see citing works
Biology of Poly(ADP-Ribose) Polymerases: The Factotums of Cell Maintenance
Bai, P. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.01.034 · Cited by 445 · see citing works
Biosynthesis of Diphosphopyridine Nucleotide
Preiss, J., & Handler, P. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64790-8 · Cited by 408 · see citing works
Biosynthesis of Diphosphopyridine Nucleotide
Preiss, J., & Handler, P. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64789-1 · Cited by 403 · see citing works
Lakso, M., Vartiainen, S., Moilanen, A., Sirviö, J., Thomas, J. H., Nass, R., Blakely, R., & Wong, G. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01809.x · Cited by 398 · see citing works
Cui, L., Supinski, A., Savas, J. N., Yates, J. R., Bordone, L., Guarente, L., Cohen, D. E., Mazzulli, J. R., Krainc, D., & Jeong, H. (2011) · PubMed Central · doi:10.1038/nm.2559 · Cited by 367 · see citing works
Self-citationJiang, M., Wang, J., Fu, J., Du, L., Jeong, H., West, T., Xiang, L., Peng, Q., Hou, Z., Cai, H., et al. (2011) · Nature Medicine · doi:10.1038/nm.2558 · Cited by 344 · see citing works
Self-citationSIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis
Luthi‐Carter, R., Taylor, D. M., Pallos, J., Lambert, E., Amore, A. M., Parker, J. A., Moffitt, H., Smith, D. L., Runne, H., Gökçe, Ö., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002924107 · Cited by 338 · see citing works
Peripheral Neuropathy Induced by Paclitaxel: Recent Insights and Future Perspectives
Scripture, C. D., Figg, W. D., & Sparreboom, A. (2006) · Current Neuropharmacology · doi:10.2174/157015906776359568 · Cited by 320 · see citing works
Alexander, A. G., Marfil, V., & Li, C. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00279 · Cited by 310 · see citing works
The kynurenine pathway and neurodegenerative disease
Maddison, D. C., & Giorgini, F. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.03.002 · Cited by 309 · see citing works
Ghosh-Roy, A., Wu, Z.-L., Goncharov, A., Jin, Y.-S., & Chisholm, A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5464-09.2010 · Cited by 304 · see citing works
Enzymology of NAD+ homeostasis in man
Magni, G., Amici, A., Emanuelli, M., Orsomando, G., Raffaelli, N., & Ruggieri, S. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3161-1 · Cited by 289 · see citing works
Reconstructing eukaryotic NAD metabolism.
Rongvaux, A., Andris, F., Gool, F. V., & Leo, O. (2003) · Bioessays · doi:10.1002/bies.10297 · Cited by 284 · see citing works
Pallos, J., Bodai, L., Lukácsovich, T., Purcell, J. M., Steffan, J. S., Thompson, L. M., & Marsh, J. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn273 · Cited by 265 · see citing works
Mitophagy in Alzheimer’s Disease and Other Age-Related Neurodegenerative Diseases
Cai, Q., & Jeong, Y. Y. (2020) · Cells · doi:10.3390/cells9010150 · Cited by 263 · see citing works
Garza-Lombó, C., Posadas, Y., Quintanar, L., Gonsebatt, M. E., & Franco, R. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7272 · Cited by 254 · see citing works
Waller, A. V. (1851) · Abstracts of the Papers Communicated to the Royal Society of London · doi:10.1098/rspl.1843.0224 · Cited by 246 · see citing works
TIR Domain Proteins Are an Ancient Family of NAD+-Consuming Enzymes
Essuman, K., Summers, D. W., Sasaki, Y., Mao, X. R., Yim, A. K., DiAntonio, A., & Milbrandt, J. (2018) · Current Biology · doi:10.1016/j.cub.2017.12.024 · Cited by 234 · see citing works
Kurnasov, O. V., Goral, V. N., Colabroy, K. L., Gerdes, S., Anantha, S., Osterman, A. L., & Begley, T. P. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.11.011 · Cited by 230 · see citing works
Microbial NAD Metabolism: Lessons from Comparative Genomics
Gazzaniga, F., Stebbins, R., Chang, S. Z., McPeek, M. A., & Brenner, C. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00042-08 · Cited by 230 · see citing works
Modeling Parkinson’s Disease in C. elegans
Cooper, J. F., & Raamsdonk, J. M. V. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-171258 · Cited by 224 · see citing works
The Sirtuin 2 Inhibitor AK-7 Is Neuroprotective in Huntington’s Disease Mouse Models
Chopra, V., Quinti, L., Kim, J., Vollor, L., Narayanan, K. L., Edgerly, C. K., Cipicchio, P. M., Lauver, M. A., Choi, S. H., Silverman, R. B., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.11.001 · Cited by 214 · see citing works
A Mechanistic Understanding of Axon Degeneration in Chemotherapy-Induced Peripheral Neuropathy
Fukuda, Y., Li, Y., & Segal, R. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00481 · Cited by 206 · see citing works
Axon Regeneration Pathways Identified by Systematic Genetic Screening in C. elegans
Chen, L., Wang, Z., Ghosh‐Roy, A., Hubert, T., Yan, D., O'Rourke, S., Bowerman, B. A., Wu, Z., Jin, Y., & Chisholm, A. D. (2011) · Neuron · doi:10.1016/j.neuron.2011.07.009 · Cited by 196 · see citing works
Benedetto, A., Au, C., Ávila, D. S., Milatović, D., & Aschner, M. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001084 · Cited by 196 · see citing works
Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders
Salvadores, N., Sanhueza, M., Manque, P., & Court, F. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00451 · Cited by 182 · see citing works
Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells
Hwang, E. S., & Song, S. B. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2527-8 · Cited by 178 · see citing works
Süßmuth, S. D., Salman, H., Landwehrmeyer, G. B., Farmer, R. E., Frost, C. D., Tripepi, G., Andersen, C. A. F., Bacco, M. D., Lamanna, C., Diodato, E., et al. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12512 · Cited by 177 · see citing works
Neugebauer, R. C., Uciechowska, U., Meier, R., Hruby, H., Valkov, V., Verdin, E. M., Sippl, W., & Jung, M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm700972e · Cited by 166 · see citing works
Therapeutic Advances for Huntington’s Disease
Kumar, A., Kumar, V., Singh, K., Kumar, S., Kim, Y.-S., Lee, Y.-M., & Kim, J.-J. (2020) · Brain Sciences · doi:10.3390/brainsci10010043 · Cited by 166 · see citing works
Self-citationNeuropathology of Degenerative Cell Death inCaenorhabditis elegans
Hall, D. H., Gong, G., Garcı́a-Añoveros, J., Gong, L., Chalfie, M., & Driscoll, M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-03-01033.1997 · Cited by 163 · see citing works
The 'dying back' process. A common denominator in many naturally occurring and toxic neuropathies.
Jb, C. (1979) · PubMed · Cited by 151 · see citing works
Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease
Ho, D. J., Calingasan, N. Y., Wille, E. J., Dumont, M., & Beal, M. F. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.05.006 · Cited by 147 · see citing works
Evidence that the Rate of Wallerian Degeneration is Controlled by a Single Autosomal Dominant Gene
Perry, V. H., Lunn, E. R., Brown, M. C., Cahusac, S., & Gordon, S. (1990) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1990.tb00433.x · Cited by 137 · see citing works
Alcaín, F. J., & Villalba, J. M. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770902762893 · Cited by 137 · see citing works
Summers, D. W., Gibson, D. A., DiAntonio, A., & Milbrandt, J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601506113 · Cited by 135 · see citing works
Brandt, R., Gergou, A., Wacker, I., Fath, T., & Hutter, H. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.011 · Cited by 126 · see citing works
Rescue of Peripheral and CNS Axon Defects in Mice Lacking NMNAT2
Gilley, J., Adalbert, R., Yu, G., & Coleman, M. P. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1534-13.2013 · Cited by 123 · see citing works
Progressive neurodegeneration in C. elegans model of tauopathy
Miyasaka, T., Ding, Z., Gengyo-Ando, K., Oue, M., Yamaguchi, H., Mitani, S., & Ihara, Y. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.03.017 · Cited by 115 · see citing works
Neurodegenerative disorders: Insights from the nematode Caenorhabditis elegans
Dimitriadi, M., & Hart, A. C. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.012 · Cited by 95 · see citing works
Metal-induced neurodegeneration in C. elegans
Chen, P., Martinez-Finley, E. J., Bornhorst, J., Chakraborty, S., & Aschner, M. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00018 · Cited by 82 · see citing works
Yaron, A., & Schuldiner, O. (2016) · Current Biology · doi:10.1016/j.cub.2016.05.025 · Cited by 76 · see citing works
Zhang, H., Zhou, T., Kurnasov, O. V., Cheek, S., Grishin, N. V., & Osterman, A. L. (2002) · Structure · doi:10.1016/s0969-2126(01)00693-1 · Cited by 74 · see citing works
Axon death signalling in Wallerian degeneration among species and in disease
Rosell, A. L., & Neukomm, L. J. (2019) · Open Biology · doi:10.1098/rsob.190118 · Cited by 74 · see citing works
Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide
Song, S. B., Park, J., Chung, G. J., Lee, I. H., & Hwang, E. S. (2019) · Metabolomics · doi:10.1007/s11306-019-1604-4 · Cited by 72 · see citing works
Calixto, A., Jara, J. S., & Court, F. A. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003141 · Cited by 66 · see citing works
Chronic Excitotoxin-Induced Axon Degeneration in a Compartmented Neuronal Culture Model
Hosie, K. A., King, A. E., Blizzard, C. A., Vickers, J. C., & Dickson, T. C. (2012) · ASN NEURO · doi:10.1042/an20110031 · Cited by 56 · see citing works
Sun, L., Shay, J., McLoed, M., Roodhouse, K., Chung, S., Clark, C. M., Pirri, J. K., Alkema, M. J., & Gabel, C. V. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4238-13.2014 · Cited by 53 · see citing works
Nmnat exerts neuroprotective effects in dendrites and axons
Wen, Y., Parrish, J. Z., He, R., Zhai, R. G., & Kim, M. D. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.05.002 · Cited by 50 · see citing works
Kim, K. W., Tang, N. H., Piggott, C. A., Andrusiak, M. G., Park, S., Zhu, M., Kurup, N. S., Cherra, S. J., Wu, Z., Chisholm, A. D., et al. (2018) · eLife · doi:10.7554/elife.39756 · Cited by 49 · see citing works
Self-citationNeuronal responses to stress and injury in C. elegans
Kim, K. W., & Jin, Y.-S. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.05.005 · Cited by 44 · see citing works
Self-citationCaito, S. W., & Aschner, M. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw030 · Cited by 43 · see citing works
Inhibiting poly(ADP-ribosylation) improves axon regeneration
Byrne, A. B., McWhirter, R. D., Sekine, Y., Strittmatter, S. M., Miller, D. M., & Hammarlund, M. (2016) · eLife · doi:10.7554/elife.12734 · Cited by 43 · see citing works
Anwar, M., Aslam, H. M., & Anwar, S. (2015) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-014-0024-8 · Cited by 43 · see citing works
Poly(ADP-ribose) polymerase 1 is a novel target to promote axonal regeneration
Brochier, C., Jones, J. I., Willis, D. E., & Langley, B. C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509754112 · Cited by 39 · see citing works
The apoptotic engulfment machinery regulates axonal degeneration in C. elegans neurons
Nichols, A. L. A., Meelkop, E., Linton, C., Giordano-Santini, R., Sullivan, R. K. P., Donato, A., Nolan, C., Hall, D. H., Xue, D., Neumann, B., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.050 · Cited by 38 · see citing works
Mitochondria and Caspases Tune Nmnat-Mediated Stabilization to Promote Axon Regeneration
Chen, L., Nye, D. M. R., Stone, M. C., Weiner, A. T., Gheres, K. W., Xiong, X., Collins, C. A., & Rolls, M. M. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006503 · Cited by 34 · see citing works
The genes pme-1 and pme-2 encode two poly(ADP-ribose) polymerases in Caenorhabditis elegans
Gagnon, S., Hengartner, M. O., & Desnoyers, S. (2002) · Biochemical Journal · doi:10.1042/bj20020669 · Cited by 29 · see citing works
Wang, X., Sekine, Y., Byrne, A. B., Cafferty, W. B. J., Hammarlund, M., & Strittmatter, S. M. (2016) · eNeuro · doi:10.1523/eneuro.0270-16.2016 · Cited by 28 · see citing works
Wang, W., McReynolds, M. R., Goncalves, J. F., Shu, M., Dhondt, I., Braeckman, B. P., Lange, S. E., Kho, K., Detwiler, A. C., Pacella, M. J., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.662916 · Cited by 26 · see citing works
Mao, X. R., Kaufman, D. M., & Crowder, C. M. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.5 · Cited by 23 · see citing works
Uridine monophosphate synthetase enables eukaryotic de novo NAD+ biosynthesis from quinolinic acid
McReynolds, M. R., Wang, W., Holleran, L. M., & Hanna‐Rose, W. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.c117.795344 · Cited by 23 · see citing works
Gubert, P., Puntel, B., Lehmen, T. F., Fessel, J. P., Cheng, P., Bornhorst, J., Trindade, L. S., Ávila, D. S., Aschner, M., & Soares, F. A. A. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.04.008 · Cited by 21 · see citing works
Maulik, M., Mitra, S., Hunter, S., Hunstiger, M., Oliver, S. R., Bult‐Ito, A., & Taylor, B. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-26905-4 · Cited by 18 · see citing works
Knock-out of a mitochondrial sirtuin protects neurons from degeneration in Caenorhabditis elegans
Sangaletti, R., D’Amico, M., Grant, J., Della‐Morte, D., & Bianchi, L. K. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006965 · Cited by 15 · see citing works
Ford, A. L., & Lee, J. (2011) · Brain Research · doi:10.1016/j.brainres.2011.07.001 · Cited by 11 · see citing works
Poly(ADP-Ribose) Metabolism Analysis in the Nematode Caenorhabditis elegans
St-Laurent, J.-F., & Desnoyers, S. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-270-0_25 · Cited by 6 · see citing works
Mechanisms of Axonal Degeneration and Regeneration
Li, J., & Collins, C. A. (2017) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190456757.013.33 · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Membrez, M., Migliavacca, E., Christen, S., Yaku, K., Trieu, J., Lee, A. K., Morandini, F., Giner, M. P., Stiner, J., Makarov, M. V., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-00997-x · Cited by 148 · see citing works
Wu, W., Gong, X.-X., Qin, Z.-H., & Wāng, Y. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01576-w · Cited by 127 · see citing works
Technology and functional insights into the nicotinamide mononucleotide for human health
Liu, Y., Gong, J., Marshall, G., Su, C., Shi, J., & Xu, Z. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12612-2 · Cited by 18 · see citing works
Dithianon exposure induces dopaminergic neurotoxicity in Caenorhabditis elegans
Lee, Y., Choi, S., & Kim, K. W. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114752 · Cited by 15 · see citing works
Self-citationRuszkiewicz, J. A., Endig, L., Güver, E., Bürkle, A., & Mangerich, A. (2023) · Cells · doi:10.3390/cells12232728 · Cited by 5 · see citing works
De novo NAD+ synthesis is ineffective for NAD+ supply in axenically cultured Caenorhabditis elegans
Zhu, S., Zhang, R., Yao, L., Lin, Z., Li, Y., Li, S., & Wu, L. (2025) · Communications Biology · doi:10.1038/s42003-025-07984-2 · Cited by 4 · see citing works
Chemical ecology of an apex predator life cyclePreprint
Mucci, N. C., Jones, K. A., Cao, M., Wyatt, M. R., Foye, S., Kauffman, S., Taufer, M., Chikaraishi, Y., Steffan, S. A., Campagna, S. R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.13.430781 · Cited by 2 · see citing works
Anticonvulsant effects of novel and repurposed drugs on docetaxel-induced neuropathy in C. elegans
Gonzalez-Lerma, P., Lloyd, C., Park, S. J., & Dawson-Scully, K. D. (2026) · PLoS ONE · doi:10.1371/journal.pone.0342236 · Cited by 2 · see citing works
- Authors
- Lee, Y., Jeong, H., Park, K. H., & Kim, K. W.
- Affiliations
- Hallym University (KR)
- Corresponding author
- Kim, Kyung Won
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2020-07-02
- Volume
- 10
- Issue
- 7
- Pages
- 993
- ISSN
- 2218-273X (ISSN-L)
- PMC
- PMC7407593
- OpenAlex
- W3038950925
- Cited by
- 8
- References
- 94
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2021: 1
- FWCI
- 0.12
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Biomolecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation of Korea (NRF-2019M3C7A1031836)
- Hallym University (HRF-202001-009)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
- Keywords
- NAD+, Caenorhabditis elegans, neuronal injury, neuroprotection, axon regeneration, axonal degeneration, excitotoxicity, NAD biosynthesis, neurodegenerative diseases, traumatic brain injury, neurotoxins
- MeSH terms
- Neuroprotection, Animals, Disease Models, Animal, NAD, Nerve Regeneration, Neurotoxins, Signal Transduction, Caenorhabditis elegans, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review